Summit Therapeutics to test ivonescimab with AstraZeneca-Daiichi ADC
Go back to Summit Therapeutics to test ivonescimab with AstraZeneca-Daiichi ADC| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 20,836 | |||||
| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 15.57 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.57 | 52 Week High | $19.75 | |||
| Open | $15.57 | 52 Week Low | $4.26 | |||
| Day High | $15.57 | P/E | N/A | |||
| Day Low | $15.57 | EPS | $0.00 | |||
| Volume | 14,176 | |||||



